Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Weighted Average): 2019-2025

Historic Shares Outstanding (Weighted Average) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $57.5 million.

  • Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) rose 1.23% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.5 million, marking a year-over-year increase of 1.23%. This contributed to the annual value of $57.0 million for FY2024, which is 0.46% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) is $57.5 million, which was up 0.19% from $57.4 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Shares Outstanding (Weighted Average) high stood at $60.0 million for Q3 2023, and its period low was $56.8 million during Q4 2023.
  • In the last 3 years, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) had a median value of $57.3 million in 2025 and averaged $57.8 million.
  • In the last 5 years, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) declined by 9.65% in 2021 and then rose by 3.78% in 2022.
  • Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) (Quarterly) stood at $58.5 million in 2021, then rose by 1.45% to $59.3 million in 2022, then decreased by 4.30% to $56.8 million in 2023, then increased by 0.46% to $57.0 million in 2024, then rose by 1.23% to $57.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $57.5 million for Q3 2025, versus $57.4 million for Q2 2025 and $57.3 million for Q1 2025.